The low affinities of the fenfluramines for the h5-HT1D/1B receptors, coupled with the observation that sumatriptan, a potent 5-HT1D/1B agonist24 widely used for treating migraine headaches, is not associated with VHD, suggests that the 5-HT1D/1B receptor